|
?:authorAffiliation
|
-
[\'Transfusion Medicine, NHS Blood and Transplant, Oxford, UK; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Radcliffe Department of Medicine and NIHR Oxford Biomedical Research Centre-Haematology Theme, University of Oxford, Oxford, UK. Electronic address: simon.stanworth@nhsbt.nhs.uk.\', \'NHS Blood and Transplant, London, UK; Department of Haematology, Imperial College London, London, UK.\', \'Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway; Norwegian Armed Forces Medical Services, Oslo, Norway.\', \'Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.\', \'NHS Blood and Transplant, Cambridge, UK; Department of Haematology, University of Cambridge, Cambridge, UK.\', \'Medical Affairs and Innovation, Héma-Québec, Québec, QC, Canada.\', \'Medical Affairs and Innovation, Canadian Blood Services, Ottawa, ON, Canada.\', \'NHS Blood and Transplant, Bristol, UK.\', \'Department of Transfusion Medicine and Hematology, IRCCS Ca \'Granda Hospital Maggiore Policlinico Foundation, Milan, Italy.\', \'Department of Medicine, Division of Haematology, Mount Sinai Hospital, ON, Canada; Department of Medicine, and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada; University Health Network, Department of Medicine, Division of Medical Oncology and Haematology, Toronto, ON, Canada.\', \'Department of Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, Netherlands; Department of Haematology, Erasmus Medical Center, Rotterdam, Netherlands.\', \'Manchester University NHS Foundation Trust, Manchester, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}